Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
September 2, 2008
STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer--a multi-arm multi-stage randomised controlled trial
N D James, M R Sydes, N W Clarke, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 16, 2013
Prostate radiotherapy for men with metastatic disease: a new comparison in the STAMPEDE trial
C C Parker, M R Sydes, M D Mason, et al.
British Journal of Cancer
|
January 11, 2007
Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer
S A Hussain, R Ganesan, G Reynolds, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 23, 2018
What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysis
C L Vale, D J Fisher, I R White, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
May 19, 2009
A cancer research UK pharmacokinetic study of BPA-mannitol in patients with high grade glioma to optimise uptake parameters for clinical trials of BNCT
G S Cruickshank, D Ngoga, A Detta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 18, 2025
Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems data
C Jones, P Dutey-Magni, L R Murphy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2025
Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
J Walz, G Attard, A Bjartell, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 16, 2023
A Repurposing Programme Evaluating Transdermal Oestradiol Patches for the Treatment of Prostate Cancer Within the PATCH and STAMPEDE Trials: Current Results and Adapting Trial Design
D C Gilbert, M Nankivell, H Rush, et al.
The New England Journal of Medicine
|
July 19, 2013
Alpha emitter radium-223 and survival in metastatic prostate cancer
C Parker, S Nilsson, D Heinrich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 10, 2023
Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer
P A Sutera, A C Shetty, A Hakansson, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
September 2, 2008
STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer--a multi-arm multi-stage randomised controlled trial
N D James, M R Sydes, N W Clarke, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 16, 2013
Prostate radiotherapy for men with metastatic disease: a new comparison in the STAMPEDE trial
C C Parker, M R Sydes, M D Mason, et al.
British Journal of Cancer
|
January 11, 2007
Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer
S A Hussain, R Ganesan, G Reynolds, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 23, 2018
What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysis
C L Vale, D J Fisher, I R White, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
May 19, 2009
A cancer research UK pharmacokinetic study of BPA-mannitol in patients with high grade glioma to optimise uptake parameters for clinical trials of BNCT
G S Cruickshank, D Ngoga, A Detta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 18, 2025
Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems data
C Jones, P Dutey-Magni, L R Murphy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2025
Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
J Walz, G Attard, A Bjartell, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 16, 2023
A Repurposing Programme Evaluating Transdermal Oestradiol Patches for the Treatment of Prostate Cancer Within the PATCH and STAMPEDE Trials: Current Results and Adapting Trial Design
D C Gilbert, M Nankivell, H Rush, et al.
The New England Journal of Medicine
|
July 19, 2013
Alpha emitter radium-223 and survival in metastatic prostate cancer
C Parker, S Nilsson, D Heinrich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 10, 2023
Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer
P A Sutera, A C Shetty, A Hakansson, et al.
Page
of 6